Why RosieVaccine exists
A personalized cancer vaccine is designed against the mutations in one individual tumor. In human oncology this approach has reached randomised trials. In veterinary medicine it has largely stayed in research settings, because the work between a biopsy and a design — sequencing, comparison, target selection, documentation — has never been assembled into something a normal clinic can actually use.
That assembly is what we build. We are not a clinic and we do not manufacture. We prepare the design package, and a veterinarian makes every clinical decision.
Who is building it
A small team: two co-founders, an oncology medical-affairs advisor, and a technical advisor in bioinformatics. Their full backgrounds, and why each of them is here, are on the team page.
Meet the team →Every application is reviewed individually. Applying does not guarantee access to a vaccine or treatment.